Barbara Gisevius
St. Josef Hospital
Bochum, NW, Germany
Bochum, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Sex-specific analysis of early disease course and treatment in a German multiple sclerosis cohort.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: June 01, 2026
Serum Neurofilament Light Chain as a Biomarker for CIDP Diagnosis, Severity, and Treatment Outcome.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: June 05, 2025
Modeling extrahepatic hepatitis E virus infection in induced human primary neurons.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 15, 2024
Oral supplementation with propionate is reflected in the serum of healthy individuals.
Journal: Therapeutic advances in neurological disorders
Published: July 12, 2024
Quality of life and tolerability of B-cell directed therapy of multiple sclerosis with ofatumumab in a patient-centered real-world observational study.
Journal: Journal of neurology
Published: May 27, 2024
Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories.
Journal: Science translational medicine
Published: March 27, 2024
Dietary galactose exacerbates autoimmune neuroinflammation via advanced glycation end product-mediated neurodegeneration.
Journal: Frontiers in immunology
Published: January 09, 2024
Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohort.
Journal: Therapeutic advances in neurological disorders
Published: May 11, 2023
Serum neurofilament light chain does not detect self-reported treatment-related fluctuations in chronic inflammatory demyelinating polyneuropathy.
Journal: European journal of neurology
Published: April 10, 2023
Propionic acid promotes neurite recovery in damaged multiple sclerosis neurons.
Journal: Brain communications
Published: April 05, 2023
Over one year of B‑cell targeted therapy with Ofatumumab s.c.: first results of a prospective, patient-centered real-world observational study
Journal: Der Nervenarzt
Published: February 16, 2023
Propionate exerts neuroprotective and neuroregenerative effects in the peripheral nervous system.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 20, 2023
Last Updated: 09/26/2026